Biopharmaceutical 3PL Market Size, Share, Trends, Growth 2032

Biopharmaceutical 3PL Market

Biopharmaceutical 3PL Market By Supply Chain (Cold Chain and Non-Cold Chain), By Service Type (Transportation, Warehousing, and Storage), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 150 Report Code: ZMR-6403 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 118.35 Billion USD 195.78 Billion 5.2% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biopharmaceutical 3PL Market, 2016–2026 (USD Billion)
    • 2.2. Biopharmaceutical 3PL Market: Snapshot
  • Chapter 3. Global Biopharmaceutical 3PL Market– Industry Analysis
    • 3.1. Biopharmaceutical 3PL Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market size over 2020-2026.
      • 3.2.2. Surge in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biulogics will favorably leverage biopharmaceutical 3PL industry growth in the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Service Type
      • 3.4.2. Market attractiveness analysis By Supply Chain
  • Chapter 4. Global Biopharmaceutical 3PL Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biopharmaceutical 3PL Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Service launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biopharmaceutical 3PL Market– Service Type Analysis
    • 5.1. Global Biopharmaceutical 3PL Market overview: By Service Type
      • 5.1.1. Global Biopharmaceutical 3PL Market share, By Service Type , 2019 and 2026
    • 5.2. Warehousing
      • 5.2.1. Global Biopharmaceutical 3PL Market By Warehousing, 2016–2026 (USD Billion)
    • 5.3. Transportation
      • 5.3.1. Global Biopharmaceutical 3PL Market By Transportation, 2016–2026 (USD Billion)
    • 5.4. Storage
      • 5.4.1. Global Biopharmaceutical 3PL Market By Storage, 2016–2026 (USD Billion)
  • Chapter 6. Global Biopharmaceutical 3PL Market– Supply Chain Analysis
    • 6.1. Global Biopharmaceutical 3PL Market overview: By Supply Chain
      • 6.1.1. Global Biopharmaceutical 3PL Market share, By Supply Chain, 2019 and 2026
    • 6.2. Culd Chain
      • 6.2.1. Global Biopharmaceutical 3PL Market By Culd Chain , 2016–2026 (USD Billion)
    • 6.3. Non-Culd Chain
      • 6.3.1. Global Biopharmaceutical 3PL Market By Non-Culd Chain, 2016–2026 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. FedEx
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Service Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. DB Schenker
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Service Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. SF Express
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Service Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. DHL International GmbH
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Service Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. United Parcel Service of America, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Service Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Kerry Logistics Network Limited
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Service Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. AmerisourceBergen Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Service Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. KUEHNE + NAGEL.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Service Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Biopharmaceutical  3PL Market attractiveness, By Service Type
6. Global Biopharmaceutical  3PL Market attractiveness, By Supply Chain
7. Global Biopharmaceutical  3PL Market Share by Service Type ,2019 and 2026 (USD Billion)
8. Global Biopharmaceutical  3PL Market by Warehousing, 2016–2026 (USD Billion)
9. Global Biopharmaceutical  3PL Market by Transportation, 2016–2026 (USD Billion)
10. Global Biopharmaceutical  3PL Market by Storage,2016–2026 (USD Billion)
11. Global Biopharmaceutical  3PL Market Share by Supply Chain ,2019 and 2026 (USD Billion)
12. Global Biopharmaceutical  3PL Market by Cold Chain  , and,2016–2026 (USD Billion)
13. Global Biopharmaceutical  3PL Market by Non-Cold Chain,2016–2026 (USD Billion)
14. Global Biopharmaceutical  3PL Market share, by Region, 2019 and 2026
15. North America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
16. Europe Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
17. Asia Pacific Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
18. Latin America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
19. The Middle East and Africa Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)


Table Of Tables

List of Tables

1. Global Biopharmaceutical  3PL Market: snapshot
2. Drivers of the Biopharmaceutical  3PL Market: impact analysis
3. North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
4. North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
5. The U.S. Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
6. The U.S. Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
7. Rest of North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
8.  Rest of North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
9.  Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
10. Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
11. UK Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
12. UK Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
13. France Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
14. France Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
15. Germany Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
16. Germany Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
17. Rest of Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
18. Rest of Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
19. Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
20. Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
21. China Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
22. China Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
23. Japan  Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
24. Japan Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
25. India Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
26. India Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
27. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
28. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
29. Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
30. Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
31. Brazil Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
32. Brazil Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
33. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
34. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
35. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
36. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
37. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
38. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
39. South Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
40. South Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
41. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
42. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)


  


 
 

Methodology

FrequentlyAsked Questions

Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market surge over 2024-2032. In addition to this, increase in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biologics will favorably leverage biopharmaceutical 3PL industry growth in the years ahead. Apart from this, rising ecological awareness among the pharma firms and means adopted by these firms for reducing GHG emissions as a part of corporate social responsibility will prompt the market size.

Furthermore, huge funding of research activities and need for creating value added services will steer the growth of biopharmaceutical 3PL industry over the upcoming years. Discovery of various kinds of precision medicines as well as regenerative drugs will bolster the expansion of biopharmaceutical 3PL industry over the ensuing years.   

Zion Market Research has published a report on the global Biopharmaceutical 3PL Market, estimating its value at USD 118.35 Billion in 2023, with projections indicating that it will reach USD 195.78 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.2% over the forecast period 2024-2032.

North America is likely to make noteworthy contributions towards overall market size over 2024-2032. The growth of the industry in the sub-continent over the estimated timespan is due to rise in the imports & exports of biopharmaceutical drugs. Apart from this, humungous healthcare spending along with massive improvement in transport & warehousing as well as logistics activities will steer the size of biopharmaceutical industry in North America over the years ahead.

The key players profiled in the report include are FedEx, DB Schenker, SF Express, DHL International GmbH, United Parcel Service of America, Inc., Kerry Logistics Network Limited, AmerisourceBergen Corporation, and KUEHNE + NAGEL.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsOverviewGrowth DynamicsReport ScopeMarket:Regional LandscapeMarket:Competitive LandscapeThe global Market is segmented as follows:

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed